37614147|t|Inhibition of abnormal C/EBPbeta/alpha-Syn signaling pathway through activation of Nrf2 ameliorates Parkinson's disease-like pathology.
37614147|a|Parkinson's disease (PD) is characterized by the formation of Lewy bodies (LBs) in the brain. These LBs are primarily composed of alpha-Synuclein (alpha-Syn), which has aggregated. A recent report proposes that CCAAT/enhancer-binding proteins beta (C/EBPbeta) may act as an age-dependent transcription factor for alpha-Syn, thereby initiating PD pathologies by regulating its transcription. Potential therapeutic approaches to address PD could involve targeting the regulation of alpha-Syn by C/EBPbeta. This study has revealed that Nrf2, also known as nuclear factor (erythroid-derived 2)-like 2 (NFE2L2), suppresses the transcription of C/EBPbeta in SH-SY5Y cells when treated with MPP+ . To activate Nrf2, sulforaphane, an Nrf2 activator, was administered. Additionally, C/EBPbeta was silenced using C/EBPbeta-DNA/RNA heteroduplex oligonucleotide (HDO). Both approaches successfully reduced abnormal alpha-Syn expression in primary neurons treated with MPP+ . Furthermore, sustained activation of Nrf2 via its activator or inhibition of C/EBPbeta using C/EBPbeta-HDO resulted in a reduction of aberrant alpha-Syn expression, thus leading to an improvement in the degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNc) in mouse models induced by 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) and those treated with preformed fibrils (PFFs). The data presented in this study illustrate that the activation of Nrf2 may provide a potential therapeutic strategy for PD by inhibiting the abnormal C/EBPbeta/alpha-Syn signaling pathway.
37614147	23	32	C/EBPbeta	Gene	1051
37614147	33	42	alpha-Syn	Gene	20617
37614147	83	87	Nrf2	Gene	4780
37614147	100	119	Parkinson's disease	Disease	MESH:D010300
37614147	136	155	Parkinson's disease	Disease	MESH:D010300
37614147	157	159	PD	Disease	MESH:D010300
37614147	198	209	Lewy bodies	Disease	MESH:D020961
37614147	211	214	LBs	Disease	MESH:D020961
37614147	236	239	LBs	Disease	MESH:D020961
37614147	266	281	alpha-Synuclein	Gene	6622
37614147	283	292	alpha-Syn	Gene	6622
37614147	385	394	C/EBPbeta	Gene	1051
37614147	449	458	alpha-Syn	Gene	6622
37614147	479	481	PD	Disease	MESH:D010300
37614147	571	573	PD	Disease	MESH:D010300
37614147	616	625	alpha-Syn	Gene	6622
37614147	629	638	C/EBPbeta	Gene	1051
37614147	669	673	Nrf2	Gene	4780
37614147	689	732	nuclear factor (erythroid-derived 2)-like 2	Gene	4780
37614147	734	740	NFE2L2	Gene	4780
37614147	775	784	C/EBPbeta	Gene	1051
37614147	788	795	SH-SY5Y	CellLine	CVCL:0019
37614147	839	843	Nrf2	Gene	4780
37614147	845	857	sulforaphane	Chemical	MESH:C016766
37614147	862	866	Nrf2	Gene	4780
37614147	910	919	C/EBPbeta	Gene	1051
37614147	939	948	C/EBPbeta	Gene	1051
37614147	1039	1048	alpha-Syn	Gene	6622
37614147	1136	1140	Nrf2	Gene	4780
37614147	1176	1185	C/EBPbeta	Gene	1051
37614147	1192	1201	C/EBPbeta	Gene	1051
37614147	1242	1251	alpha-Syn	Gene	20617
37614147	1302	1338	degeneration of dopaminergic neurons	Disease	MESH:D009410
37614147	1410	1454	1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine	Chemical	-
37614147	1456	1460	MPTP	Chemical	-
37614147	1578	1582	Nrf2	Gene	4780
37614147	1632	1634	PD	Disease	MESH:D010300
37614147	1662	1671	C/EBPbeta	Gene	1051
37614147	1672	1681	alpha-Syn	Gene	20617
37614147	Association	MESH:D009410	20617
37614147	Negative_Correlation	1051	4780
37614147	Negative_Correlation	MESH:D009410	1051
37614147	Positive_Correlation	MESH:C016766	4780
37614147	Association	MESH:D010300	4780
37614147	Association	MESH:D020961	1051
37614147	Association	MESH:D010300	6622
37614147	Association	1051	6622
37614147	Association	MESH:D010300	1051
37614147	Association	MESH:D009410	4780
37614147	Association	MESH:D020961	6622
37614147	Negative_Correlation	1051	20617
37614147	Association	MESH:D010300	20617
37614147	Negative_Correlation	20617	4780

